Summary Keywords glucagon-like peptide-1 receptor, Alzheimers disease, diabetes mellitus, insulin resistance, neuroinflammation Citation Li S, Huang N, Wang M, Huang W, Shi J, Luo Y and Huang J (2025) GLP-1R as a potential link between diabetes and Alzheimers disease
They are best administered as part of a strategic, comprehensive wellness program with an experienced practitioner that first considers other medical, diet and lifestyle interventions
Choosing a trained specialist can greatly rescue these risks
Plateau at week 46 with clean execution
They are approved only for type 2 diabetes management and chronic weight management in specific formulations